Literature DB >> 29762177

Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study.

Samantha A Molsberry1, Yu Cheng2,3, Lawrence Kingsley4,5, Lisa Jacobson6, Andrew J Levine7, Eileen Martin8, Eric N Miller7, Cynthia A Munro9,10, Ann Ragin11, Ned Sacktor10, James T Becker3,12,13.   

Abstract

OBJECTIVE: Mild forms of HIV-associated neurocognitive disorder (HAND) remain prevalent in the combination antiretroviral therapy (cART) era. This study's objective was to identify neuropsychological subgroups within the Multicenter AIDS Cohort Study (MACS) based on the participant-based latent structure of cognitive function and to identify factors associated with subgroups.
DESIGN: The MACS is a four-site longitudinal study of the natural and treated history of HIV disease among gay and bisexual men.
METHODS: Using neuropsychological domain scores, we used a cluster variable selection algorithm to identify the optimal subset of domains with cluster information. Latent profile analysis was applied using scores from identified domains. Exploratory and posthoc analyses were conducted to identify factors associated with cluster membership and the drivers of the observed associations.
RESULTS: Cluster variable selection identified all domains as containing cluster information except for Working Memory. A three-profile solution produced the best fit for the data. Profile 1 performed below average on all domains, Profile 2 performed average on executive functioning, motor, and speed and below average on learning and memory, Profile 3 performed at or above average across all domains. Several demographic, cognitive, and social factors were associated with profile membership; these associations were driven by differences between Profile 1 and the other profiles.
CONCLUSION: There is an identifiable pattern of neuropsychological performance among MACS members determined by all domains except Working Memory. Neither HIV nor HIV-related biomarkers were related with cluster membership, consistent with other findings that cognitive performance patterns do not map directly onto HIV serostatus.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29762177      PMCID: PMC6082155          DOI: 10.1097/QAD.0000000000001865

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  29 in total

1.  Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men.

Authors:  E N Miller; P Satz; B Visscher
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

2.  Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study.

Authors:  Samantha A Molsberry; Fabrizio Lecci; Lawrence Kingsley; Brian Junker; Sandra Reynolds; Karl Goodkin; Andrew J Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor; James T Becker
Journal:  AIDS       Date:  2015-03-27       Impact factor: 4.177

Review 3.  Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review.

Authors:  J Michaels; L R Sharer; L G Epstein
Journal:  Immunodefic Rev       Date:  1988

4.  Clinical and epidemiologic features of primary HIV infection.

Authors:  T Schacker; A C Collier; J Hughes; T Shea; L Corey
Journal:  Ann Intern Med       Date:  1996-08-15       Impact factor: 25.391

5.  Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors.

Authors:  Diana De Ronchi; Irma Faranca; Domenico Berardi; Paolo Scudellari; Marco Borderi; Roberto Manfredi; Laura Fratiglioni
Journal:  Arch Neurol       Date:  2002-05

6.  Cohort Profile: Recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study.

Authors:  James T Becker; Lawrence A Kingsley; Samantha Molsberry; Sandra Reynolds; Aaron Aronow; Andrew J Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor; Ola A Selnes
Journal:  Int J Epidemiol       Date:  2014-04-24       Impact factor: 7.196

Review 7.  Neurological complications of HIV infection.

Authors:  Justin C McArthur; Bruce J Brew; Avi Nath
Journal:  Lancet Neurol       Date:  2005-09       Impact factor: 44.182

8.  Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study.

Authors:  L A Kingsley; R Detels; R Kaslow; B F Polk; C R Rinaldo; J Chmiel; K Detre; S F Kelsey; N Odaka; D Ostrow
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

9.  Variable patterns of neuropsychological performance in HIV-1 infection.

Authors:  S Dawes; P Suarez; C Y Casey; M Cherner; T D Marcotte; S Letendre; I Grant; R K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2008-03-04       Impact factor: 2.475

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more
  6 in total

1.  Empiric neurocognitive performance profile discovery and interpretation in HIV infection.

Authors:  Daniela Gomez; Christopher Power; M John Gill; Noshin Koenig; Roberto Vega; Esther Fujiwara
Journal:  J Neurovirol       Date:  2018-12-05       Impact factor: 2.643

Review 2.  Neurocognitive Phenotyping of HIV in the Era of Antiretroviral Therapy.

Authors:  Robert Paul
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

3.  Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda.

Authors:  Leah H Rubin; Deanna Saylor; Gertrude Nakigozi; Noeline Nakasujja; Kevin Robertson; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Sarah M Lofgren; David R Boulware; Raha Dastgheyb; Steven J Reynolds; Thomas C Quinn; Ronald H Gray; Maria J Wawer; Ned Sacktor
Journal:  J Neurovirol       Date:  2019-06-19       Impact factor: 2.643

4.  Cognitive Trajectory Phenotypes in Human Immunodeficiency Virus-Infected Patients.

Authors:  Raha M Dastgheyb; Ned Sacktor; Donald Franklin; Scott Letendre; Thomas Marcotte; Robert Heaton; Igor Grant; Justin C McArthur; Leah H Rubin; Norman J Haughey
Journal:  J Acquir Immune Defic Syndr       Date:  2019-09-01       Impact factor: 3.771

5.  Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV.

Authors:  Raha M Dastgheyb; Alison S Buchholz; Kathryn C Fitzgerald; Yanxun Xu; Dionna W Williams; Gayle Springer; Kathryn Anastos; Deborah R Gustafson; Amanda B Spence; Adaora A Adimora; Drenna Waldrop; David E Vance; Joel Milam; Hector Bolivar; Kathleen M Weber; Norman J Haughey; Pauline M Maki; Leah H Rubin
Journal:  Front Neurol       Date:  2021-02-11       Impact factor: 4.003

6.  Associations between Antiretrovirals and Cognitive Function in Women with HIV.

Authors:  Leah H Rubin; Yuliang Li; Yanxun Xu; Dionna W Williams; Kathryn C Fitzgerald; Raha Dastgheyb; Amanda B Spence; Pauline M Maki; Anjali Sharma; Deborah R Gustafson; Joel Milam; Kathleen M Weber; Adaora A Adimora; Norman J Haughey; Igho Ofotokun; Margaret A Fischl; Deborah Konkle-Parker
Journal:  J Neuroimmune Pharmacol       Date:  2020-03-24       Impact factor: 7.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.